Cargando…

Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma

Detalles Bibliográficos
Autores principales: Dillman, Robert, Cornforth, Andrew, Bayer, Michael, Carbonell, Dynesha, Nistor, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288727/
http://dx.doi.org/10.1186/2051-1426-2-S3-P70
_version_ 1782352014653521920
author Dillman, Robert
Cornforth, Andrew
Bayer, Michael
Carbonell, Dynesha
Nistor, Gabriel
author_facet Dillman, Robert
Cornforth, Andrew
Bayer, Michael
Carbonell, Dynesha
Nistor, Gabriel
author_sort Dillman, Robert
collection PubMed
description
format Online
Article
Text
id pubmed-4288727
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42887272015-01-15 Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma Dillman, Robert Cornforth, Andrew Bayer, Michael Carbonell, Dynesha Nistor, Gabriel J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288727/ http://dx.doi.org/10.1186/2051-1426-2-S3-P70 Text en Copyright © 2014 Dillman et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Dillman, Robert
Cornforth, Andrew
Bayer, Michael
Carbonell, Dynesha
Nistor, Gabriel
Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
title Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
title_full Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
title_fullStr Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
title_full_unstemmed Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
title_short Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
title_sort phase iii randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288727/
http://dx.doi.org/10.1186/2051-1426-2-S3-P70
work_keys_str_mv AT dillmanrobert phaseiiirandomizeddoubleblindedplacebocontrolledmulticentertrialofmelapuldenciltautologousdendriticcellsloadedwithirradiatedautologoustumorcellsdctcingmcsfinpatientswithmetastaticmelanoma
AT cornforthandrew phaseiiirandomizeddoubleblindedplacebocontrolledmulticentertrialofmelapuldenciltautologousdendriticcellsloadedwithirradiatedautologoustumorcellsdctcingmcsfinpatientswithmetastaticmelanoma
AT bayermichael phaseiiirandomizeddoubleblindedplacebocontrolledmulticentertrialofmelapuldenciltautologousdendriticcellsloadedwithirradiatedautologoustumorcellsdctcingmcsfinpatientswithmetastaticmelanoma
AT carbonelldynesha phaseiiirandomizeddoubleblindedplacebocontrolledmulticentertrialofmelapuldenciltautologousdendriticcellsloadedwithirradiatedautologoustumorcellsdctcingmcsfinpatientswithmetastaticmelanoma
AT nistorgabriel phaseiiirandomizeddoubleblindedplacebocontrolledmulticentertrialofmelapuldenciltautologousdendriticcellsloadedwithirradiatedautologoustumorcellsdctcingmcsfinpatientswithmetastaticmelanoma